Nanotechnology-enabled pharmaceuticals and biomaterials: Innovations in drug delivery, theranostics, and clinical translation
Letters in Drug Design & Discovery · 2026-07 · 23 (7) · 100528
DOI: 10.1016/j.lddd.2026.100528 ↗Kurz gefasst
Fachartikel in der Zeitschrift Letters in Drug Design & Discovery, 2026-07. Verfasst von Mirunalini Gobinath und 7 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 173 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Gobinath, M., Mukherjee, S., Soundarya, R., Halagali, P., Seenivasan, R., Rai, S. N., Singh, P., & Sharma, H. (2026). Nanotechnology-enabled pharmaceuticals and biomaterials: Innovations in drug delivery, theranostics, and clinical translation. Letters in Drug Design & Discovery, 23(7), 100528. https://doi.org/10.1016/j.lddd.2026.100528
Vancouver
Gobinath M, Mukherjee S, Soundarya R, Halagali P, Seenivasan R, Rai SN, et al. Nanotechnology-enabled pharmaceuticals and biomaterials: Innovations in drug delivery, theranostics, and clinical translation. Letters in Drug Design & Discovery. 2026;23(7):100528. doi:10.1016/j.lddd.2026.100528
BibTeX
@article{Gobinath2026,
author = {Gobinath, Mirunalini and Mukherjee, Sagarika and Soundarya, R. and Halagali, Praveen and Seenivasan, Raagul and Rai, Sachchida Nand and Singh, Payal and Sharma, Himanshu},
title = {Nanotechnology-enabled pharmaceuticals and biomaterials: Innovations in drug delivery, theranostics, and clinical translation},
journal = {Letters in Drug Design & Discovery},
year = {2026},
volume = {23},
number = {7},
pages = {100528},
doi = {10.1016/j.lddd.2026.100528}
}
EUVIMED